Sensorion strives to be the first to bring effective drug candidates to patients with inner ear disorders. 

Our efficient, in-house, Research and Development platform:
 - Was developed based on our scientific expertise and years of international research on the inner ear, 
 - Incorporates the most recent scientific advances for in vitro and functional cellular ex vivo assays, in-vivo disease models, pharmacokinetics & pharmacodynamics and toxicology studies,
 - Allows for a reproducible process for developing next-generation products,
 - Is dedicated to discovering first-in-class drug candidates for dysfunctions of the inner ear.

plateform

Latest news

  • 06 Jun 2018

    Sensorion Announces Oral Presentation at the 15th International Conference on Cochlear Implants and Other Implantable Auditory Technologies (Ci2018). Read Sensorion Announces Oral Presentation at the 15th International Conference on Cochlear Implants and Other Implantable Auditory Technologies (Ci2018)

  • 04 Jun 2018

    Sensorion’s Chair of Scientific Advisory Board, Prof. Christine Petit, Awarded 2018 Kavli Prize in Neuroscience. Read

Patient center

Corporate presentation